Cardiovascular Disease Risk Estimation in China
Authors: Paul K. Whelton, Lisandro D. Colantonio
Journal: Annals of Internal Medicine (2019)

Editorials5 March 2019Cardiovascular Disease Risk Estimation in ChinaPaul K. Whelton, MB, MD, MSc and Lisandro D. Colantonio, MD, PhDPaul K. Whelton, MB, MD, MScTulane University, New Orleans, Louisiana (P.K.W.) and Lisandro D. Colantonio, MD, PhDUniversity of Alabama at Birmingham, Birmingham, Alabama (L.D.C.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/M18-3301 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail As early as the 1920s, the insurance industry had identified several factors that predict future cardiovascular disease (CVD) events. In the 1940s, the Framingham Heart Study formalized and served as a leader in the CVD risk prediction process. In recent years, various CVD risk prediction models have been developed and recommended in clinical practice guidelines. Much of the focus has been on high-income countries, where CVD risk prediction instruments have included several traditional risk factors, such as age, sex, race, blood pressure, hypertension treatment, lipid levels, smoking status, presence or absence of diabetes (1), and sometimes statin and aspirin treatment ...References1. Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49-73. [PMID: 24222018] doi:10.1161/01.cir.0000437741.48606.98 CrossrefMedlineGoogle Scholar2. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1-45. [PMID: 24222016] doi:10.1161/01.cir.0000437738.63853.7a CrossrefMedlineGoogle Scholar3. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71:1269-1324. [PMID: 29133354] doi:10.1161/HYP.0000000000000066 CrossrefMedlineGoogle Scholar4. Bibbins-Domingo K; U.S. Preventive Services Task Force. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164:836-45. [PMID: 27064677]. doi:10.7326/M16-0577 LinkGoogle Scholar5. World Health Organization. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Cardiovascular Disease. Geneva: WHO Pr; 2007. Google Scholar6. Lu J, Lu Y, Yang H, Bilige W, Li Y, Schulz W, et al. Characteristics of high cardiovascular risk in 1.7 million Chinese adults. Ann Intern Med. 2019;170:298-308. doi:10.7326/M18-1932 LinkGoogle Scholar7. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al; Inter-ASIA Collaborative Group. The International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002;40:920-7. [PMID: 12468580] CrossrefMedlineGoogle Scholar8. Yang X, Li J, Hu D, Chen J, Li Y, Huang J, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in chinese population: the China-PAR project (Prediction for ASCVD risk in China). Circulation. 2016;134:1430-1440. [PMID: 27682885] CrossrefMedlineGoogle Scholar9. Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, et al; USA-PRC Collaborative Study of Cardiovascular and Cardiopulmonary Epidemiology Research Group. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation. 2006;114:2217-25. [PMID: 17088464] CrossrefMedlineGoogle Scholar10. Bress AP, Colantonio LD, Cooper RS, Kramer H, Booth JN, Odden MC, et al. Potential cardiovascular disease events prevented with adoption of the 2017 American College of Cardiology/American Heart Association blood pressure guideline. Circulation. 2019;139:24-36. [PMID: 30586736] doi:10.1161/CIRCULATIONAHA.118.03564010 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Tulane University, New Orleans, Louisiana (P.K.W.)University of Alabama at Birmingham, Birmingham, Alabama (L.D.C.)Grant Support: Dr. Whelton was supported by Centers for Biomedical Research Excellence grant P20GM109036 from the National Institute of General Medical Sciences.Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3301.Corresponding Author: Paul K. Whelton, MB, MD, MSc, 1440 Canal Street, Room 20XX, New Orleans, LA 70112; e-mail, [email protected]com.Current Author Addresses: Dr. Whelton: 1440 Canal Street, Room 20XX, New Orleans, LA 70112.Dr. Colantonio: Department of Epidemiology, University of Alabama at Birmingham, 1700 University Boulevard, Suite 446, Birmingham, AL 35294.This article was published at Annals.org on 19 February 2019. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoCharacteristics of High Cardiovascular Risk in 1.7 Million Chinese Adults Jiapeng Lu , Yuan Lu , Hao Yang , Wuhan Bilige , Yetong Li , Wade Schulz , Frederick A. Masoudi , and Harlan M. Krumholz Metrics Cited byWhole grain cereals: the potential roles of functional components in human healthValidating World Health Organization cardiovascular disease risk charts and optimizing risk assessment in ChinaEvolution of Blood Pressure Clinical Practice Guidelines: A Personal Perspective 5 March 2019Volume 170, Issue 5Page: 340-341KeywordsAntihypertensive drug therapyAspirinAtherosclerotic cardiovascular diseaseCardiovascular diseasesChartsCongenital heart diseaseMedical risk factorsMyocardial infarctionRisk managementStatins ePublished: 19 February 2019 Issue Published: 5 March 2019 Copyright & PermissionsCopyright © 2019 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...